Central Nervous System

Covering both psychiatric and neurological indications, Decision Resources assesses the overall clinical and commercial environment for central nervous system (CNS) drug therapies to offer organizations an invaluable guide for understanding these markets.  Averaging 10 reports per year, Decision Resources offers one of the largest CNS portfolios available from a market research firm.

Some of the most popular Decision Resources’ CNS reports include:

• Multiple Sclerorsis
• Mild Cognitive Impairment
• Major Depressive Disorder
• Insomnia
• Bipolar Disorder
• Alzheimer’s Disease

Upcoming CNS Reports:

• Alzheimer’s Disease in China
• Schizophrenia
• Parkinson’s Disease
• Epilepsy
• ADHD
• Neuropathic Pain

~If you don't find a topic or disease in our list of publications, please call (toll free in the U.S.: +1-866-296-8352) or email us so that we can guide you to related or upcoming coverage or discuss a customized project through our consulting group.